2022 full-year results:
Revenue up 41%.
Positive EBITDA for the year.
A sharp improvement in results, in line with guidance.
Well positioned to confirm this trajectory in 2023.
Strengthened cash flow.
More information at: CP-VOGO-RA-2022-EN.pdf (vogo-group.com)
Share this article:
The collaboration of VOGO and Sys2Diag did not end with the EasyCov project. When researchers at the famous research laboratory learned about the functionality and performance of the VOKKERO GUARDIAN systems marketed by VOGO, they immediately understood how much help they could give them in many of their daily tasks. The example of the clinical study…